HEPLISAV

hepatitis B vaccine · Dynavax Technologies Corporation

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for HEPLISAV, covering 2014-05-26 to 2019-03-20. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of HEPLISAV™ a Hepatitis B Virus Vaccine in Adults on Hemodialysis [Phase 3]